Skip to content
The Nexus
DossierENTITY

Senate Committee on Finance

Coverage of Senate Committee on Finance in the Nexus archive.

Earliest in view: Apr 22 · 21:23 UTCMost recent: May 26 · 08:30 UTC
Co-mentioned in this coverage
John Cornynperson1Richard Gonzalezperson1AbbVieorganization1Humiratopic1rheumatoid arthritistopic1inflammatory bowel diseasetopic1FDAorganization1Robert F. Kennedy Jr.person1Department of Health and Human Servicesorganization1President Donald Trumpperson1measles outbreakstopic1vaccination ratestopic1Kim Schrierperson1Centers for Disease Control and Prevention (CDC)organization1
Recent coverage
  • BUSINESSMay 26 · 08:30 UTCSTAT NEWS
    Opinion: The innovation trap: How pharma weaponizes a word to extend monopolies

    Sen. John Cornyn questioned AbbVie CEO Richard Gonzalez during a 2019 congressional hearing about the company's 136 patents on Humira, a drug with the same active molecule used to treat multiple conditions. Gonzalez defended the patents as 'innovations,' extending patent protection beyond the original 2016 expiry. The exchange highlights concerns about pharmaceutical companies leveraging patent portfolios to maintain monopolies.

  • HEALTHApr 22 · 21:23 UTCAP NEWS
    Vaccines, budget cuts and affordability: Takeaways from RFK Jr’s gauntlet of congressional hearings

    HHS Secretary Robert F. Kennedy Jr. testified before Congress defending President Trump’s 2027 budget, which proposes a 12% cut to HHS funding, while deflecting blame for declining vaccination rates and measles outbreaks. Kennedy attributed the issues to global trends and loss of public trust in government health guidance, despite critics linking his past anti-vaccine advocacy to eroded trust in federal health agencies.